{"nct_id":"NCT01486446","title":"Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia","status":"COMPLETED","status_verified_date":"2014-03","start_date":"2011-12","start_date_type":null,"primary_completion_date":"2012-04","primary_completion_date_type":"ACTUAL","completion_date":"2012-05","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["XENE"]}